Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 von Lok, Anna S, Gardiner, David F, Lawitz, Eric, Martorell, Claudia, Everson, Gregory T, Ghalib, Reem, Reindollar, Robert, Rustgi, Vinod, McPhee, Fiona, Wind-Rotolo, Megan, Persson, Anna, Zhu, Kurt, Dimitrova, Dessislava I, Eley, Timothy, Guo, Tong, Grasela, Dennis M, Pasquinelli, Claudio

Volltext

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection von Afdhal, Nezam, Reddy, K. Rajender, Nelson, David R, Lawitz, Eric, Gordon, Stuart C, Schiff, Eugene, Nahass, Ronald, Ghalib, Reem, Gitlin, Norman, Herring, Robert, Lalezari, Jacob, Younes, Ziad H, Pockros, Paul J, Di Bisceglie, Adrian M, Arora, Sanjeev, Subramanian, G. Mani, Zhu, Yanni, Dvory-Sobol, Hadas, Yang, Jenny C, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Sulkowski, Mark, Kwo, Paul

Volltext

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis von Kowdley, Kris V, Gordon, Stuart C, Reddy, K. Rajender, Rossaro, Lorenzo, Bernstein, David E, Lawitz, Eric, Shiffman, Mitchell L, Schiff, Eugene, Ghalib, Reem, Ryan, Michael, Rustgi, Vinod, Chojkier, Mario, Herring, Robert, Di Bisceglie, Adrian M, Pockros, Paul J, Subramanian, G. Mani, An, Di, Svarovskaia, Evguenia, Hyland, Robert H, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Pound, David, Fried, Michael W

Volltext

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus von Thompson, Alexander J, Muir, Andrew J, Sulkowski, Mark S, Ge, Dongliang, Fellay, Jacques, Shianna, Kevin V, Urban, Thomas, Afdhal, Nezam H, Jacobson, Ira M, Esteban, Rafael, Poordad, Fred, Lawitz, Eric J, McCone, Jonathan, Shiffman, Mitchell L, Galler, Greg W, Lee, William M, Reindollar, Robert, King, John W, Kwo, Paul Y, Ghalib, Reem H, Freilich, Bradley, Nyberg, Lisa M, Zeuzem, Stefan, Poynard, Thierry, Vock, David M, Pieper, Karen S, Patel, Keyur, Tillmann, Hans L, Noviello, Stephanie, Koury, Kenneth, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, Goldstein, David B, McHutchison, John G

Volltext

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and trea... von Lawitz, Eric, Prof, Sulkowski, Mark S, Prof, Ghalib, Reem, MD, Rodriguez-Torres, Maribel, MD, Younossi, Zobair M, Prof, Corregidor, Ana, MD, DeJesus, Edwin, MD, Pearlman, Brian, Prof, Rabinovitz, Mordechai, Prof, Gitlin, Norman, MD, Lim, Joseph K, MD, Pockros, Paul J, MD, Scott, John D, MD, Fevery, Bart, MSc, Lambrecht, Tom, MSc, Ouwerkerk-Mahadevan, Sivi, PhD, Callewaert, Katleen, MSc, Symonds, William T, PharmD, Picchio, Gaston, PhD, Lindsay, Karen L, MD, Beumont, Maria, MD, Jacobson, Ira M, Prof

Volltext

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection... von Lawitz, Eric, Prof, Gane, Edward, Prof, Pearlman, Brian, Prof, Tam, Edward, MD, Ghesquiere, Wayne, Prof, Guyader, Dominique, Prof, Alric, Laurent, MD, Bronowicki, Jean-Pierre, Prof, Lester, Laura, MSN, Sievert, William, Prof, Ghalib, Reem, MD, Balart, Luis, MD, Sund, Fredrik, MD, Lagging, Martin, Prof, Dutko, Frank, PhD, Shaughnessy, Melissa, MS, Hwang, Peggy, PhD, Howe, Anita Y M, PhD, Wahl, Janice, MD, Robertson, Michael, MD, Barr, Eliav, MD, Haber, Barbara, MD

Volltext

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection von McHutchison, John G, Lawitz, Eric J, Shiffman, Mitchell L, Muir, Andrew J, Galler, Greg W, McCone, Jonathan, Nyberg, Lisa M, Lee, William M, Ghalib, Reem H, Schiff, Eugene R, Galati, Joseph S, Bacon, Bruce R, Davis, Mitchell N, Mukhopadhyay, Pabak, Koury, Kenneth, Noviello, Stephanie, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, Sulkowski, Mark S

Volltext

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection von Muir, Andrew J, Arora, Sanjeev, Everson, Gregory, Flisiak, Robert, George, Jacob, Ghalib, Reem, Gordon, Stuart C, Gray, Todd, Greenbloom, Susan, Hassanein, Tarek, Hillson, Jan, Horga, Maria Arantxa, Jacobson, Ira M, Jeffers, Lennox, Kowdley, Kris V, Lawitz, Eric, Lueth, Stefan, Rodriguez-Torres, Maribel, Rustgi, Vinod, Shemanski, Lynn, Shiffman, Mitchell L, Srinivasan, Subasree, Vargas, Hugo E, Vierling, John M, Xu, Dong, Lopez-Talavera, Juan C, Zeuzem, Stefan

Volltext

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial von Pol, Stanislas, Dr Prof, Ghalib, Reem H, Prof, Rustgi, Vinod K, Prof, Martorell, Claudia, Prof, Everson, Greg T, Prof, Tatum, Harvey A, Prof, Hézode, Christophe, Prof, Lim, Joseph K, Prof, Bronowicki, Jean-Pierre, Prof, Abrams, Gary A, Prof, Bräu, Norbert, Prof, Morris, David W, Prof, Thuluvath, Paul J, Prof, Reindollar, Robert W, Prof, Yin, Philip D, MD, Diva, Ulysses, PhD, Hindes, Robert, MD, McPhee, Fiona, PhD, Hernandez, Dennis, PhD, Wind-Rotolo, Megan, PhD, Hughes, Eric A, MD, Schnittman, Steven, MD

Volltext

Survey of Women Physicians' Experience with Elected Leadership Positions von Shillcutt, Sasha K, Parangi, Sareh, Diekman, Sarah, Ghalib, Reem, Schoenthaler, Robin, Girgis, Linda M, Parekh, Ranna, Bhargava, Hansa, Silver, Julie K

Volltext

Racial differences in hepatitis C treatment eligibility von Melia, Michael T., Muir, Andrew J., McCone, Jonathan, Shiffman, Mitchell L., King, John W., Herrine, Steven K., Galler, Greg W., Bloomer, Joseph R., Nunes, Frederick A., Brown, Kimberly A., Mullen, Kevin D., Ravendhran, Natarajan, Ghalib, Reem H., Boparai, Navdeep, Jiang, Ruiyun, Noviello, Stephanie, Brass, Clifford A., Albrecht, Janice K., McHutchison, John G., Sulkowski, Mark S.

Volltext

Analysis of Gender Equity in Leadership of Physician-Focused Medical Specialty Societies, 2008-2017 von Silver, Julie K, Ghalib, Reem, Poorman, Julie A, Al-Assi, Dana, Parangi, Sareh, Bhargava, Hansa, Shillcutt, Sasha K

Volltext

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension von Chalasani, Naga, Abdelmalek, Manal F., Garcia-Tsao, Guadalupe, Vuppalanchi, Raj, Alkhouri, Naim, Rinella, Mary, Noureddin, Mazen, Pyko, Maxmillan, Shiffman, Mitchell, Sanyal, Arun, Allgood, Adam, Shlevin, Harold, Horton, Rex, Zomer, Eliezer, Irish, William, Goodman, Zachary, Harrison, Stephen A., Traber, Peter G., Abdelmalek, Manal, Balart, Luis, Borg, Brian, Chalasani, Naga, Charlton, Michael, Conjeevaram, Hari, Fuchs, Michael, Ghalib, Reem, Gholam, Pierre, Halegoua-De Marzio, Dina, Harrison, Stephen, Jue, Christopher, Kemmer, Nyingi, Kowdley, Kris, Lai, Michelle, Lawitz, Eric, Loomba, Rohit, Noureddin, Mazen, Paredes, Angelo, Rinella, Mary, Rockey, Don, Rodriguez, Miguel, Rubin, Raymond, Ryan, Michael, Sanyal, Arun, Scanga, Andrew, Sepe, Thomas, Shiffman, Mitchell, Tetri, Brent, Thuluvath, Paul, Torres, Dawn, Vierling, John, Wattacheril, Julia, Weiland, Amanda, Zogg, Donald

Volltext

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multi... von Forns, Xavier, Lee, Samuel S, Valdes, Joaquin, Lens, Sabela, Ghalib, Reem, Aguilar, Humberto, Felizarta, Franco, Hassanein, Tarek, Hinrichsen, Holger, Rincon, Diego, Morillas, Rosa, Zeuzem, Stefan, Horsmans, Yves, Nelson, David R, Yu, Yao, Krishnan, Preethi, Lin, Chih-Wei, Kort, Jens J, Mensa, Federico J

Volltext

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study von Nelson, David R., Cooper, James N., Lalezari, Jacob P., Lawitz, Eric, Pockros, Paul J., Gitlin, Norman, Freilich, Bradley F., Younes, Ziad H., Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J., Ortiz‐Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M., Varunok, Peter, Kowdley, Kris V., Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A.

Volltext

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection von Rodriguez-Torres, Maribel, Läwitz, Eric, Yangco, Bienvenido, Jeffers, Lennox, Han, Steven-Huy, Thuluvath, Paul J, Rustgi, Vinod, Harrison, Stephen, Ghalib, Reem, Vierling, John M, Luketic, Velimir, Zamor, Philippe J, Ravendhran, Natarajan, Morgan, Timothy R, Pearlman, Brian, O’Brien, Christopher, Khallafi, Hicham, Pyrsopoulos, Nikolaos, Kong, George, McPhee, Fiona, Yin, Philip D, Hughes, Eric, Treitel, Michelle

Volltext

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis von Harrison, Stephen A., Abdelmalek, Manal F., Caldwell, Stephen, Shiffman, Mitchell L., Diehl, Anna Mae, Ghalib, Reem, Lawitz, Eric J., Rockey, Don C., Schall, Raul Aguilar, Jia, Catherine, McColgan, Bryan J., McHutchison, John G., Subramanian, G. Mani, Myers, Robert P., Younossi, Zobair, Ratziu, Vlad, Muir, Andrew J., Afdhal, Nezam H., Goodman, Zachary, Bosch, Jaime, Sanyal, Arun J.

Volltext

SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treat... von Younossi, Zobair M, Lawitz, Eric J, Krastev, Zahary, Rigney, Amy, Tchernev, Konstantin, Takov, Dimitar, Ghalib, Reem H, Long, Walker A

Volltext

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection von Foster, Graham R, Afdhal, Nezam, Roberts, Stuart K, Bräu, Norbert, Gane, Edward J, Pianko, Stephen, Lawitz, Eric, Thompson, Alex, Shiffman, Mitchell L, Cooper, Curtis, Towner, William J, Conway, Brian, Ruane, Peter, Bourlière, Marc, Asselah, Tarik, Berg, Thomas, Zeuzem, Stefan, Rosenberg, William, Agarwal, Kosh, Stedman, Catherine A.M, Mo, Hongmei, Dvory-Sobol, Hadas, Han, Lingling, Wang, Jing, McNally, John, Osinusi, Anu, Brainard, Diana M, McHutchison, John G, Mazzotta, Francesco, Tran, Tram T, Gordon, Stuart C, Patel, Keyur, Reau, Nancy, Mangia, Alessandra, Sulkowski, Mark

Volltext

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2) von Lawitz, Eric, Matusow, Gary, DeJesus, Edwin, Yoshida, Eric M., Felizarta, Franco, Ghalib, Reem, Godofsky, Eliot, Herring, Robert W., Poleynard, Gary, Sheikh, Aasim, Tobias, Hillel, Kugelmas, Marcelo, Kalmeijer, Ronald, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Sinha, Rekha, Witek, James

Volltext